Forecast: Domestic Private Health Expenditure in United Arab Emirates

By analyzing the provided data for domestic private health expenditure in the United Arab Emirates, we notice a continuous upward trend. From 2023, the value stood at a baseline of X US Dollars Per Capita (data for this year is repeated, but it is consistent). In 2024, it increased to 959.93, and by 2028 it is forecasted to reach 1060. This represents a compound annual growth rate (CAGR) that demonstrates consistent growth in health expenditure per capita.

Year-on-year variations show:

- 2024-2025: An increase from 959.93 to 985.37, which is approximately a 2.65% rise.

- 2025-2026: An increment from 985.37 to 1010, reflecting around a 2.5% increase.

- 2026-2027: An increase from 1010 to 1040, which represents nearly a 2.97% growth.

- 2027-2028: A rise from 1040 to 1060, indicating an increase of roughly 1.92%.

The compound annual growth rate (CAGR) from 2023 to 2028 indicates consistent annual growth in domestic private health expenditure in the UAE.

Future trends to watch for include potential governmental policy changes impacting healthcare funding, technological advancements in healthcare provision, and the evolving demographics and health needs of the population. An increase in lifestyle diseases could also drive up private health expenditure.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease